|
PIAS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.21009999973521E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.76559999970949E-07 |
| Normal-vs-Stage2 |
4.804300E-03 |
| Normal-vs-Stage3 |
3.123500E-03 |
| Normal-vs-Stage4 |
2.963500E-04 |
| Stage1-vs-Stage2 |
4.854800E-01 |
| Stage1-vs-Stage3 |
6.671600E-01 |
| Stage1-vs-Stage4 |
5.346000E-01 |
| Stage2-vs-Stage3 |
7.534800E-01 |
| Stage2-vs-Stage4 |
2.121200E-01 |
| Stage3-vs-Stage4 |
3.584400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.92480000002793E-07 |
| Normal-vs-AfricanAmerican |
3.16300000002823E-06 |
| Normal-vs-Asian |
1.729600E-01 |
| Caucasian-vs-AfricanAmerican |
7.991000E-01 |
| Caucasian-vs-Asian |
9.936400E-01 |
| AfricanAmerican-vs-Asian |
9.281400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.07739999646961E-08 |
| Normal-vs-Female |
2.890200E-02 |
| Male-vs-Female |
1.112240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.796700E-04 |
| Normal-vs-Extreme_Weight |
5.70589999693283E-08 |
| Normal-vs-Obese |
2.183000E-04 |
| Normal-vs-Extreme_Obese |
4.790000E-04 |
| Normal_Weight-vs-Extreme_Weight |
3.189800E-01 |
| Normal_Weight-vs-Obese |
6.271200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.406600E-01 |
| Extreme_Weight-vs-Obese |
7.585600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.337000E-01 |
| Obese-vs-Extreme_Obese |
3.687000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.938300E-02 |
| Normal-vs-Age(41-60Yrs) |
6.013500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.75030000493237E-08 |
| Normal-vs-Age(81-100Yrs) |
7.33479999959208E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.707200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.008200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.224760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.911600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.962600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.178600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.11149999707061E-08 |
| Normal-VS-Type2 PRCC |
5.85960000000219E-05 |
| Normal-VS-KIRP CIMP |
1.267960E-02 |
| Normal-VS-Unclassified PRCC |
1.117960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.889200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.662000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.614200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.778000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.567640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.671000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.0485999996378E-07 |
| Normal-vs-N1 |
2.891900E-02 |
| Normal-vs-N2 |
5.063700E-03 |
| N0-vs-N1 |
6.606000E-02 |
| N0-vs-N2 |
8.187600E-01 |
| N1-vs-N2 |
3.517200E-01 |
|
|
